hanmi

Hanmi Fine Chemical Launches CDMO Business

Korea’s Hanmi Fine Chemical, which specializes in developing and manufacturing APIs, is launching a CDMO business. The Seoul-based company will invest about 10 billion Korean won to build what it terms “high-tech” CDMO facilities.

News

Janssen Boosts Metabolism Portfolio with Hanmi Biologic

News

Sanofi Collaborates on Diabetes with Lexicon and Hanmi

Top-Feature

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Bio-Rad Laboratories

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Sasol

Leading Transformation

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

hanmi

Hanmi Fine Chemical Launches CDMO Business

Janssen Boosts Metabolism Portfolio with Hanmi Biologic

Sanofi Collaborates on Diabetes with Lexicon and Hanmi

Top-Feature

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

Anchored in Sustainability